ACS Medicinal Chemistry Letters

Displaying 1 - 4 of 4
Park, S.-Y., Pham, D., Shukla, P., Edward, J., John, R., Li, A., Hadjiargyrou, M., Mori, M., Zuccarello, E., Arancio, O., & Fiorito, J. (2025). Discovery of Indole-Based PDE5 Inhibitors: Synthesis and Pharmacological Evaluation. ACS Medicinal Chemistry Letters, 16(6), 1058–1065. https://doi.org/10.1021/acsmedchemlett.5c00108
Publication Date
Smith, N., Reznik, E., Bisikirska, B., Polychronidou, V., Wang, Q., Zask, A., Forouhar, F., Califano, A., & Stockwell, B. R. (2023). Kinases Controlling Stability of the Oncogenic MYCN Protein. ACS Medicinal Chemistry Letters, 14(12), 1664–1672. https://doi.org/10.1021/acsmedchemlett.3c00274
Publication Date
Chaplain, C., Fritschi, C. J., Anang, S., Gong, Z., Richard, J., Bourassa, C., Liang, S., Mohammadi, M., Park, J., Finzi, A., Madani, N., Sodroski, J. G., Abrams, C. F., Hendrickson, W. A., & Smith, A. B. (2022). Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines. ACS Medicinal Chemistry Letters, 14(1), 51–58. https://doi.org/10.1021/acsmedchemlett.2c00376
Publication Date
Fritschi, C. J., Liang, S., Mohammadi, M., Anang, S., Moraca, F., Chen, J., Madani, N., Sodroski, J. G., Abrams, C. F., Hendrickson, W. A., & Smith, A. B. (2021). Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics. ACS Medicinal Chemistry Letters, 12(11), 1824–1831. https://doi.org/10.1021/acsmedchemlett.1c00437
Publication Date